Markets Wrap – Tue, 31 Jan ‘23: Stocks rise, rupee falls; Asia, Europe markets, Gold, Crude, Crypto updates

Domestic indices recovered losses on Tuesday and closed in the green territory, reacting positively to the Economic Survey 2023. The BSE Sensex closed above 59,500 and the NSE Nifty 50 settled above 17,660. The top gainers of the BSE Sensex were Mahindra & Mahindra (up 3.53%), UltraTech Cement (up 3.09%), Power Grid (up 3.02%), State […]

Rupee likely to depreciate on strong dollar, risk aversion in markets; USDINR pair to trade in this range

The India Rupee is likely to depreciate on Friday on the back of a strong dollar, rise in crude oil prices and risk aversion in global markets. Market sentiments were hurt as major central across the globe signalled that interest rates will go higher despite recessionary fears. Additionally, investors will remain cautious ahead of manufacturing […]

L&T: Deal will be a one-off gain

Construction major Larsen & Toubro and Canadian pension fund manager Canada Pension Plan Investment Board (CPP) have sold their 100% stake in L&T IDPL, infra asset ownership entity, for `6,000 crore EV. `2,720 crore  is the gross equity receipts with L&T’s 51% share implying `1,390 crore receipt.  Buoyant equity markets is helping L&T with its […]

Indian Railways to operate four special suburban services in Mumbai on New Year’s Eve to service passengers 

To serve the influx of commuters on New Year’s Eve, the Central Railway has announced that four special suburban trains will facilitate passengers between midnight of December 31, 2023 and January 1, 2024.These four special trains will cater to the rush as peoplefrom extended suburbs visit famous locations like the Gateway of India in south […]

Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData

Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, exagamglogene autotemcel (Casgevy). However, given that 88% of CRISPR drugs are in the early stages of development, it is unlikely to see another CRISPR approval any time soon, says GlobalData, a leading data and analytics company. In November […]

网站备案号: 粤ICP备16118000号-1